HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,925,000 | +14.6% | 200,098 | +8.9% | 0.01% | +25.0% |
| Q2 2023 | $15,644,000 | +4.6% | 183,738 | +1.7% | 0.00% | 0.0% |
| Q1 2023 | $14,957,000 | -8.3% | 180,750 | -12.8% | 0.00% | -20.0% |
| Q4 2022 | $16,312,000 | +26.0% | 207,392 | +18.6% | 0.01% | +25.0% |
| Q3 2022 | $12,943,000 | +32.9% | 174,818 | +17.0% | 0.00% | +33.3% |
| Q2 2022 | $9,739,000 | +2.7% | 149,412 | -0.4% | 0.00% | +50.0% |
| Q1 2022 | $9,485,000 | -41.3% | 150,013 | -50.8% | 0.00% | -50.0% |
| Q4 2021 | $16,160,000 | -30.9% | 304,653 | -8.1% | 0.00% | -33.3% |
| Q3 2021 | $23,391,000 | +6.4% | 331,358 | +0.4% | 0.01% | 0.0% |
| Q2 2021 | $21,986,000 | +5.1% | 329,918 | +75.0% | 0.01% | 0.0% |
| Q1 2021 | $20,927,000 | -36.1% | 188,516 | -31.7% | 0.01% | -33.3% |
| Q4 2020 | $32,754,000 | +11.5% | 275,810 | -18.1% | 0.01% | -10.0% |
| Q3 2020 | $29,386,000 | +108.4% | 336,789 | +113.9% | 0.01% | +66.7% |
| Q2 2020 | $14,101,000 | -2.2% | 157,457 | +8.8% | 0.01% | -14.3% |
| Q1 2020 | $14,416,000 | +204.9% | 144,656 | +251.4% | 0.01% | +250.0% |
| Q4 2019 | $4,728,000 | -32.2% | 41,161 | -25.5% | 0.00% | -33.3% |
| Q3 2019 | $6,972,000 | -76.3% | 55,280 | -77.4% | 0.00% | -75.0% |
| Q2 2019 | $29,425,000 | +21.1% | 244,522 | -12.0% | 0.01% | +20.0% |
| Q1 2019 | $24,304,000 | +36.2% | 277,814 | +55.7% | 0.01% | +11.1% |
| Q4 2018 | $17,850,000 | -49.5% | 178,415 | -42.2% | 0.01% | -40.0% |
| Q3 2018 | $35,372,000 | -24.9% | 308,710 | -41.2% | 0.02% | -28.6% |
| Q2 2018 | $47,094,000 | -1.7% | 525,133 | -19.8% | 0.02% | 0.0% |
| Q1 2018 | $47,899,000 | +11.8% | 654,729 | -11.2% | 0.02% | +10.5% |
| Q4 2017 | $42,831,000 | +22.1% | 737,428 | -5.7% | 0.02% | +11.8% |
| Q3 2017 | $35,079,000 | +27.0% | 781,795 | +11.8% | 0.02% | +21.4% |
| Q2 2017 | $27,619,000 | -2.1% | 699,408 | +0.6% | 0.01% | -6.7% |
| Q1 2017 | $28,216,000 | +9.6% | 695,465 | +8.6% | 0.02% | +7.1% |
| Q4 2016 | $25,733,000 | +24.3% | 640,105 | +12.0% | 0.01% | +16.7% |
| Q3 2016 | $20,697,000 | +22.9% | 571,596 | -1.6% | 0.01% | +20.0% |
| Q2 2016 | $16,836,000 | -16.7% | 580,771 | +0.5% | 0.01% | -23.1% |
| Q1 2016 | $20,216,000 | +9.4% | 577,927 | +0.8% | 0.01% | +8.3% |
| Q4 2015 | $18,481,000 | -4.0% | 573,249 | -3.7% | 0.01% | -14.3% |
| Q3 2015 | $19,246,000 | -23.4% | 595,456 | -2.0% | 0.01% | -17.6% |
| Q2 2015 | $25,118,000 | -11.9% | 607,329 | -4.3% | 0.02% | -15.0% |
| Q1 2015 | $28,501,000 | +22.2% | 634,491 | +1.8% | 0.02% | +33.3% |
| Q4 2014 | $23,317,000 | +1.6% | 623,100 | -5.2% | 0.02% | -6.2% |
| Q3 2014 | $22,952,000 | -4.6% | 657,274 | -3.6% | 0.02% | 0.0% |
| Q2 2014 | $24,064,000 | +5.8% | 682,111 | -2.2% | 0.02% | -5.9% |
| Q1 2014 | $22,740,000 | -18.5% | 697,785 | +5.4% | 0.02% | -15.0% |
| Q4 2013 | $27,892,000 | +436.3% | 662,045 | +407.7% | 0.02% | +400.0% |
| Q3 2013 | $5,201,000 | +12.6% | 130,395 | +16.7% | 0.00% | 0.0% |
| Q2 2013 | $4,619,000 | – | 111,710 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |